Skip to main content

Search

10 result(s) for 'author#Zizheng Wang' within BMC

Page 1 of 1

Sort by: Relevance | Date

  1. Retroperitoneoscopic surgery has shown advantages in urological surgery. However, its application in pancreatic surgery for neoplasm is rare. Robotic surgical system with its magnified view and flexible instru...

    Authors: Guodong Zhao, Zizheng Wang, Minggen Hu, Sai Chou, Xin Ma, Xiangjun Lv, Zhiming Zhao, Yong Xu, Zhipeng Zhou and Rong Liu
    Citation: World Journal of Surgical Oncology 2018 16:171
  2. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Jing Di, Ibrar Siddique, Zizheng Li, Ghattas Malki, Simon Hornung, Suman Dutta, Ian Hurst, Ella Ishaaya, Austin Wang, Sally Tu, Ani Boghos, Ida Ericsson, Frank-Gerrit Klärner, Thomas Schrader and Gal Bitan
    Citation: Alzheimer's Research & Therapy 2021 13:88

    The original article was published in Alzheimer's Research & Therapy 2021 13:6

  3. Intrahepatic cholangiocarcinoma (ICC) is a fatal primary liver cancer, and its long-term survival rate remains poor. RNA-binding proteins (RBPs) play an important role in critical cellular processes, failure o...

    Authors: Wenbo Zou, Zizheng Wang, Xiuping Zhang, Shuai Xu, Fei Wang, Lincheng Li, Zhaoda Deng, Jing Wang, Ke Pan, Xinlan Ge, Chonghui Li, Rong Liu and Minggen Hu
    Citation: Cancer Cell International 2021 21:657
  4. This study determined the regulatory effects of inducible T-cell co-stimulators (ICOS) in human hepatocellular carcinoma HepG2 cells using a RNA interference (RNAi) technique.

    Authors: Yaning Wei, Yanan Wang, Aimin Zang, Yanhong Shang, Zizheng Song, Zhiyu Wang, Yangyang Wang and Hua Yang
    Citation: Biological Research 2018 51:2
  5. Pancreatic head adenocarcinoma (PHAC), a malignant tumour, has a very poor prognosis, and the existing prognostic tools lack good predictive power. This study aimed to develop a better nomogram to predict over...

    Authors: Wenbo Zou, Zizheng Wang, Fei Wang, Gong Zhang and Rong Liu
    Citation: BMC Cancer 2021 21:524
  6. Long non-coding RNA (lncRNA) plays a critical role in the malignant progression of intrahepatic cholangiocarcinoma (iCCA). This study aimed to establish a 4-lncRNA prognostic signature and explore correspondin...

    Authors: Wenbo Zou, Zizheng Wang, Fei Wang, Lincheng Li, Rong Liu and Minggen Hu
    Citation: BMC Cancer 2021 21:608
  7. Acquirement of resistance is always associated with a highly aggressive phenotype of tumor cells. Recent studies have revealed that Annexin A2 (Anxa2) is a key protein that links drug resistance and cancer met...

    Authors: Yanling Fan, Weiyao Si, Wei Ji, Zhiyong Wang, Zicong Gao, Ran Tian, Weijie Song, He Zhang, Ruifang Niu and Fei Zhang
    Citation: Breast Cancer Research 2019 21:66
  8. Molecular tweezers (MTs) are broad-spectrum inhibitors of abnormal protein aggregation. A lead MT, called CLR01, has been demonstrated to inhibit the aggregation and toxicity of multiple amyloidogenic proteins...

    Authors: Jing Di, Ibrar Siddique, Zizheng Li, Ghattas Malki, Simon Hornung, Suman Dutta, Ian Hurst, Ella Ishaaya, Austin Wang, Sally Tu, Ani Boghos, Ida Ericsson, Frank-Gerrit Klärner, Thomas Schrader and Gal Bitan
    Citation: Alzheimer's Research & Therapy 2021 13:6

    The Correction to this article has been published in Alzheimer's Research & Therapy 2021 13:88

  9. Shortening the standard 6-month treatment for drug-susceptible pulmonary tuberculosis (DS-PTB) would be a major improvement for TB case management and disease control.

    Authors: Mengqiu Gao, Jingtao Gao, Jian Du, Yuhong Liu, Yao Zhang, Liping Ma, Fengling Mi, Liang Li and Shenjie Tang
    Citation: BMC Infectious Diseases 2017 17:435
  10. Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common potentially life-threatening inherited kidney diseases. It is the fourth most common cause of end-stage renal disease requiring re...

    Authors: Jing Gan, Yansheng Wu, Xuezhong Gong, Yiyi Ma, Shengqiang Yu and Jiandong Gao
    Citation: Trials 2019 20:481